BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10426126)

  • 1. Increased c-myc oncogene expression in Ewing's sarcoma: correlation with Ki67 proliferation index.
    Sollazzo MR; Benassi MS; Magagnoli G; Gamberi G; Molendini L; Ragazzini P; Merli M; Ferrari C; Balladelli A; Picci P
    Tumori; 1999; 85(3):167-73. PubMed ID: 10426126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcome.
    Amir G; Issakov J; Meller I; Sucher E; Peyser A; Cohen IJ; Yaniv I; Ben Arush MW; Tavori U; Kollender Y; Ron N; Peylan-Ramu N
    Hum Pathol; 2002 Feb; 33(2):170-4. PubMed ID: 11957141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycolysis- and immune-related novel prognostic biomarkers of Ewing's sarcoma: glucuronic acid epimerase and triosephosphate isomerase 1.
    Jiang J; Zhan X; Xu G; Liang T; Yu C; Liao S; Chen L; Huang S; Sun X; Yi M; Zhang Z; Yao Y; Liu C
    Aging (Albany NY); 2021 Jul; 13(13):17516-17535. PubMed ID: 34233293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma.
    Fuchs B; Inwards CY; Janknecht R
    Clin Cancer Res; 2004 Feb; 10(4):1344-53. PubMed ID: 14977835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
    Fellinger EJ; Garin-Chesa P; Glasser DB; Huvos AG; Rettig WJ
    Am J Surg Pathol; 1992 Aug; 16(8):746-55. PubMed ID: 1497115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.
    Zia H; Murray GI; Vyhlidal CA; Leeder JS; Anwar AE; Bui MM; Ahmed AA
    Int J Exp Pathol; 2015 Apr; 96(2):81-6. PubMed ID: 25670065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
    Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
    Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.
    Cotterill SJ; Ahrens S; Paulussen M; Jürgens HF; Voûte PA; Gadner H; Craft AW
    J Clin Oncol; 2000 Sep; 18(17):3108-14. PubMed ID: 10963639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological outcomes of patients with Ewing's sarcoma: is there a difference between skeletal and extra-skeletal Ewing's sarcoma?
    Pradhan A; Grimer RJ; Spooner D; Peake D; Carter SR; Tillman RM; Abudu A; Jeys L
    J Bone Joint Surg Br; 2011 Apr; 93(4):531-6. PubMed ID: 21464495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
    Merchant MS; Woo CW; Mackall CL; Thiele CJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
    Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
    Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins.
    Fuchs B; Inwards C; Scully SP; Janknecht R
    Clin Orthop Relat Res; 2004 Sep; (426):64-8. PubMed ID: 15346053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumors.
    López-Guerrero JA; Machado I; Scotlandi K; Noguera R; Pellín A; Navarro S; Serra M; Calabuig-Fariñas S; Picci P; Llombart-Bosch A
    Int J Cancer; 2011 Mar; 128(5):1139-50. PubMed ID: 20473914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1.
    Lu Q; Lu M; Li D; Zhang S
    Mol Med Rep; 2018 Oct; 18(4):3577-3588. PubMed ID: 30106161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming cetuximab resistance in Ewing's sarcoma by inhibiting lactate dehydrogenase-A.
    Fu J; Jiang H; Wu C; Jiang Y; Xiao L; Tian Y
    Mol Med Rep; 2016 Jul; 14(1):995-1001. PubMed ID: 27222229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.